AFFiRiS
AFFiRiS is an innovative, Vienna-based biotechnology company. Using its proprietary AFFITOME® – technology, it is able to develop customised peptide-based vaccines targeting Alzheimer’s disease, Parkinson’s disease, atherosclerosis, hypertension and other diseases with unmet medical needs.
Details:
Incorporation: 2003
Branche: Pharma R&D
Focus: peptid-based vaccines
Headquarters: Vienna, Austria
Website: www.affiris.com
Biocrates
Biocrates dedicate themselves to developing improved diagnostics, thus enabling the administration of personalized medicine catered to the special needs of one person. This is achieved by developing novel biomarkers by means of a metabolomics, a newly established technology that combines the characteristic metabolic attributes of cells or any biological organism. Consequently those biomarkers make it possible to detect predispositions for certain illnesses, diagnose illnesses and support treatment decisions.
Details:
Incorporation: 2002
Branche: Life Sciences
Focus: Biomarker, Diagnostics, Metabolomics
Headquarters: Innsbruck, Austria
Website: www.biocrates.com
Eucodis
White biotechnology involves usage of biological agents and lipases as well as other enzymes for the production of medicines, cosmetics, functional food and numerous other areas. EUCODIS Bioscience is a developer and producer of novel enzymes for industrial purposes. Enzymes substitute complex synthesis procedures by means of biocatalyst production procedures, thus certain ways of production become more economic and environmental friendly. The company came out with numerous novel enzymes, such as lipases, phosolipases and beta-lactamase. EUCODIS Bioscience uses vivo-recombination technique, a proven technology for direct evolution of enzymes, to produce custom made enzymes specifically for the customers’ needs.
Details:
Incorporation: 2007
Branche: White Biotech
Focus: Enzyme Engineering
Headquarters: Vienna, Austria
Website: www.eucodisbioscience.com
Marinomed
Marinomed is a biopharmaceutical company discovering and developing innovative naturally-derived immunological and antiviral treatments.
The company has its present laboratories and offices at the campus of the University of Veterinary Medicine in Vienna. Therefore, the impressive infrastructure of this university and various synergies with well respected departments at the campus can be utilized.
Marinomed already brought their antiviral nasal spray against common cold to the market in several European countries. In addition they successfully outlicenced the rights to introduce the nasal spray in many other countries to Boehringer Ingelheim.
Details:
Incorporation: 2006
Branche: Development of Antiviral & immunological treatments
Focus: Aommon cold, influeza and other respiratory diseases
Headquarters: Vienna, Austria
Website: www.marinomed.com
Nabriva
Nabriva Therapeutics is an Austrian biotechnology company operating worldwide and specialized in the development of innovative antibiotics against infectious diseases, which are hard to treat due to high antibiotic resistances of the pathogens. Nabriva has a multifaceted and promising pipeline of antibacterial compounds which show positive results and high efficacy against existing resistances. Admission to the market is one of the current projects and a Phase II study has just been successfully completed.
Details:
Incorporation: 2006
Branche: Pharma R&D
Focus: Antibiotics
Headquarters: Vienna, Austria
Website: www.nabriva.com